Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kestra Med Technologies LtdSHS SHS | 0 | 2,728,679 | +2,728,679 | $0 | $77.19M | 43.94% | +$77.19M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 1,591,917 | +1,591,917 | $0 | $40.00M | 22.77% | +$40.00M |
| Avalyn Pharma Inc.(AVLN) | 0 | 929,824 | +929,824 | $0 | $26.49M | 15.08% | +$26.49M |
| Agomab Therapeutics NvADS | 0 | 1,538,702 | +1,538,702 | $0 | $17.08M | 9.72% | +$17.08M |
| Inventiva SaADS | 0 | 3,633,181 | +3,633,181 | $0 | $13.41M | 7.63% | +$13.41M |
| Evommune Inc | 0 | 97,362 | +97,362 | $0 | $804.2K | 0.46% | +$804.2K |
| Nyxoah S ASHS SHS | 0 | 522,057 | +522,057 | $0 | $720.4K | 0.41% | +$720.4K |